Hide

FocusBar

Subscribe to Premium Member
Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 2/10

vs
industry
vs
history
Cash to Debt 0.732
OMCM's Cash to Debt is ranked lower than
85% of the 1027 Companies
in the Global Software - Infrastructure industry.

( Industry Median: 51.37 vs. OMCM: 0.732 )
OMCM' s 10-Year Cash to Debt Range
Min: 0   Max: 1.25
Current: 0.73

0
1.25
Equity to Asset -10.426
OMCM's Equity to Asset is ranked lower than
114155% of the 876 Companies
in the Global Software - Infrastructure industry.

( Industry Median: 0.54 vs. OMCM: -10.426 )
OMCM' s 10-Year Equity to Asset Range
Min: -17.33   Max: 0.11
Current: -10.43

-17.33
0.11
Interest Coverage 0.3
OMCM's Interest Coverage is ranked lower than
99% of the 797 Companies
in the Global Software - Infrastructure industry.

( Industry Median: 10000.00 vs. OMCM: 0.3 )
OMCM' s 10-Year Interest Coverage Range
Min: 0   Max: 0
Current: 0.3

F-Score: 2
Z-Score: -47.07
M-Score: -14.42
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 3/10

vs
industry
vs
history
Operating margin (%) 3.90
OMCM's Operating margin (%) is ranked lower than
79% of the 759 Companies
in the Global Software - Infrastructure industry.

( Industry Median: 9.00 vs. OMCM: 3.90 )
OMCM' s 10-Year Operating margin (%) Range
Min: -8416.9   Max: 3.9
Current: 3.9

-8416.9
3.9
Net-margin (%) -50.4
OMCM's Net-margin (%) is ranked lower than
135869% of the 736 Companies
in the Global Software - Infrastructure industry.

( Industry Median: 7.30 vs. OMCM: -50.4 )
OMCM' s 10-Year Net-margin (%) Range
Min: -8545.1   Max: -25.2
Current: -50.4

-8545.1
-25.2
ROA (%) -281.9
OMCM's ROA (%) is ranked lower than
136426% of the 733 Companies
in the Global Software - Infrastructure industry.

( Industry Median: 5.90 vs. OMCM: -281.9 )
OMCM' s 10-Year ROA (%) Range
Min: -814.4   Max: -76
Current: -281.9

-814.4
-76
Revenue Growth (%) 10.7
OMCM's Revenue Growth (%) is ranked higher than
58% of the 417 Companies
in the Global Software - Infrastructure industry.

( Industry Median: 9.00 vs. OMCM: 10.7 )
OMCM' s 10-Year Revenue Growth (%) Range
Min: -47.9   Max: 56.5
Current: 10.7

-47.9
56.5
EPS Growth (%) -2.6
OMCM's EPS Growth (%) is ranked lower than
396825% of the 252 Companies
in the Global Software - Infrastructure industry.

( Industry Median: 15.20 vs. OMCM: -2.6 )
OMCM' s 10-Year EPS Growth (%) Range
Min: -38.5   Max: 13.6
Current: -2.6

-38.5
13.6
» OMCM's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Insider Trades

Latest Guru Trades with OMCM



No Insider Trades Found!

Ratios

vs
industry
vs
history
P/S 0.90
OMCM's P/S is ranked higher than
63% of the 1037 Companies
in the Global Software - Infrastructure industry.

( Industry Median: 1.60 vs. OMCM: 0.90 )
OMCM' s 10-Year P/S Range
Min: 0.19   Max: 125
Current: 0.9

0.19
125
EV-to-EBIT 20.4
OMCM's EV-to-EBIT is ranked lower than
58% of the 818 Companies
in the Global Software - Infrastructure industry.

( Industry Median: 15.61 vs. OMCM: 20.4 )
OMCM' s 10-Year EV-to-EBIT Range
Min: 17.9   Max: 55.2
Current: 20.4

17.9
55.2

Valuation & Return

vs
industry
vs
history
Price/Net Current Asset Value 16
OMCM's Price/Net Current Asset Value is ranked lower than
59% of the 709 Companies
in the Global Software - Infrastructure industry.

( Industry Median: 11.80 vs. OMCM: 16 )
OMCM' s 10-Year Price/Net Current Asset Value Range
Min: 4.5   Max: 65
Current: 16

4.5
65
Price/Median PS Value 0.2
OMCM's Price/Median PS Value is ranked higher than
98% of the 992 Companies
in the Global Software - Infrastructure industry.

( Industry Median: 1.10 vs. OMCM: 0.2 )
OMCM' s 10-Year Price/Median PS Value Range
Min: 0.1   Max: 15.6
Current: 0.2

0.1
15.6
Earnings Yield (Greenblatt) 4.90
OMCM's Earnings Yield (Greenblatt) is ranked lower than
58% of the 826 Companies
in the Global Software - Infrastructure industry.

( Industry Median: 6.20 vs. OMCM: 4.90 )
OMCM' s 10-Year Earnings Yield (Greenblatt) Range
Min: 1.8   Max: 5.6
Current: 4.9

1.8
5.6
Forward Rate of Return (Yacktman) -21.88
OMCM's Forward Rate of Return (Yacktman) is ranked lower than
316455% of the 316 Companies
in the Global Software - Infrastructure industry.

( Industry Median: 12.15 vs. OMCM: -21.88 )
OMCM' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -36.4   Max: -15.7
Current: -21.88

-36.4
-15.7

Business Description

OmniComm Systems, InCorporation was originally organized as Coral Development Corp., under the laws of the State of Delaware, on November 19, 1996. On February 17, 1999, OmniComm Systems, Inc., a Company organized under the laws of the State of Florida as the Premisys Group, Inc. on March 4, 1997, merged with Coral Development. Coral Development was the surviving entity post-merger. The merged entity changed its name to OmniComm Systems, Inc. The Company provides Electronic Data Capture (EDC) solutions and related value-added services to pharmaceutical and biotechnology companies, Clinical Research Organizations (CRO), and other clinical trial sponsors via its Web-based software, TrialMaster. Trial Master is designed to allow clinical trial sponsors and investigative sites to easily and securely collect, validate, transmit, and analyze clinical study data. TrialMaster is a 21 CFR Part 11 compliant solution and designed to offer clinical trial sponsors the ability to conduct clinical trials under multiple platforms, with significant flexibility, ease-of-use and complete control over collected data. Developed using forward-looking technology based on Microsoft(r).NET architecture, TrialMaster provides a simple 'drag and drop' design tool and a straightforward, logical build process that allows easy and rapid trial development. TrialMaster offers significant business benefits to its customers and is designed to help clinical trial sponsors more efficiently conduct their clinical trials. The Company also provides business process consulting services that aim at more effectively integrating EDC processes into the clinical trial process. Its goal is to provide its clients a data collection process that is streamlined, efficient and cost-effective. TrialMaster has been designed to make the trial building process more efficient than the technologies deployed by its competitors. The benefits of managing a clinical trial using TrialMaster for EDC include: Real-Time Access to the Data, Faster Study Completion and Cost Savings. Its representative customers include pharmaceutical, biotechnology, medical device, academic research institutions, CROs and other clinical trial sponsors. The Company sells its products through a direct sales force and through its relationships with CROs. The market for electronic data collection, data management and adverse event reporting systems is highly competitive, rapidly evolving, fragmented and is subject to changing technology, shifting customer needs and frequent introductions of new products and services. The Company competes with systems and paper-based processes utilized by existing or prospective customers, as well as other commercial vendors of EDC applications, clinical data management systems and adverse event reporting software. The conduct of clinical trials is subject to regulation and regulatory guidance associated with the approval of new drugs, biological products and medical devices imposed u
Company Website
SEC Reports
Industry: Software - Infrastructure
Compare:
» More Articles for OMCM

Headlines

Articles On GuruFocus.com

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names
Free 7-day Trial